BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24978327)

  • 1. Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
    Garzon JG; Bassa P; Moragas M; Soler M; Riera E
    Clin Nucl Med; 2014 Aug; 39(8):742-3. PubMed ID: 24978327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-choline PET/CT and PSA kinetics.
    Castellucci P; Picchio M
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1():S36-40. PubMed ID: 23579864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    World J Urol; 2015 Nov; 33(11):1749-52. PubMed ID: 25824540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
    Garcia JR; Jorcano S; Soler M; Linero D; Moragas M; Riera E; Miralbell R; Lomeña F
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):342-50. PubMed ID: 24844254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
    Bertagna F; Bertoli M; Treglia G; Manenti S; Salemme M; Giubbini R
    Clin Nucl Med; 2014 Oct; 39(10):e442-4. PubMed ID: 24561683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹¹C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes.
    Welle CL; Cullen EL; Peller PJ; Lowe VJ; Murphy RC; Johnson GB; Binkovitz LA
    Radiographics; 2016; 36(1):279-92. PubMed ID: 26761541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
    Reske SN; Moritz S; Kull T
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):430-9. PubMed ID: 23069922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.
    Fuccio C; Castellucci P; Schiavina R; Guidalotti PL; Gavaruzzi G; Montini GC; Nanni C; Marzola MC; Rubello D; Fanti S
    Eur J Radiol; 2012 Aug; 81(8):e893-6. PubMed ID: 22621862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
    Castellucci P; Ceci F; Graziani T; Schiavina R; Brunocilla E; Mazzarotto R; Pettinato C; Celli M; Lodi F; Fanti S
    J Nucl Med; 2014 Sep; 55(9):1424-9. PubMed ID: 24935990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.
    Garcia JR; Cuberas G; Riera E; Soler M; Moragas M; Lomeña F
    Nucl Med Commun; 2015 Jan; 36(1):8-15. PubMed ID: 25299466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
    Giovacchini G; Picchio M; Garcia-Parra R; Mapelli P; Briganti A; Montorsi F; Gianolli L; Messa C
    J Urol; 2013 Jan; 189(1):105-10. PubMed ID: 23164385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
    Incerti E; Fodor A; Mapelli P; Fiorino C; Alongi P; Kirienko M; Giovacchini G; Busnardo E; Gianolli L; Di Muzio N; Picchio M
    J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
    Mapelli P; Busnardo E; Magnani P; Freschi M; Picchio M; Gianolli L; Messa C
    Clin Nucl Med; 2012 Jun; 37(6):593-5. PubMed ID: 22614195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.
    Krause BJ; Souvatzoglou M; Tuncel M; Herrmann K; Buck AK; Praus C; Schuster T; Geinitz H; Treiber U; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):18-23. PubMed ID: 17891394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of second tumors in 11C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer].
    García JR; Ponce A; Canales M; Ayuso J; Moragas M; Soler M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):28-31. PubMed ID: 23499124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy.
    Giovacchini G; Picchio M; Parra RG; Briganti A; Gianolli L; Montorsi F; Messa C
    Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
    Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.